MAY 1, 2008
PHOX2B sequencing begins for Congential Central Hypoventilation Syndrome

APRIL 22, 2008
Ambry Genetics Announces Next Generation Sequencing Services for Support of Pharmacogenomics Research.

MARCH 5, 2008
Insulin gene sequencing joins Neonatal Diabetes panel..

JANUARY 28, 2008
Ambry Genetics Creates New Business Division to Support Biopharmaceutical Research

AUGUST 13, 2007
First Clinical Genetic Test for Idiopathic Pulmonary Fibrosis Launched

AUGUST 30, 2005
Ambry Genetics Expands and Relocates to Larger Facility

JUNE 1, 2005
CLEP of New York Grants Ambry Genetics Certification Status

MAY 20, 2005
Gross Deletion Detection Now Available with The Ambry Test for Cystic Fibrosis

FEBRUARY 11, 2005
Ambry Genetics Launches New Genetic Test for Hemoglobin Disorders

DECEMBER 21, 2004
Ambry Genetics Awarded College of American Pathologists Accreditation
Now part of an exclusive group of more than 6,000 laboratories worldwide that have met the highest standards of excellence

DECEMBER 17, 2004
James Thompson MD, PhD Joins Ambry Genetics as Medical Director Ambry Genetics Names Luke Padwick, MD, MS to its Board of Directors

NOVEMBER 22, 2004
Ambry Genetics Launches New Website
www.ambrygen.com Offers Expanded Content for Medical Professionals and Customers

NOVEMBER 12, 2004
Research testing for ADRB2 now available at Ambry Genetics

NOVEMBER 10, 2004
Ambry Genetics Expands CFTR Testing
Now Accepting Bloodspots for Full Gene Sequence Analysis

OCTOBER 5, 2004
Ambry Genetics Names Timothy Vo, PhD, FACMG Laboratory Director